Are Essential Oils Really Effective? Science Is Unsure As Well
Are essential oils really effective? Turns out, science is unsure as well. Source link...
Tag : Medicines
Medicines for All Institute partners with South African manufacturer to increase access to lifesaving drugs
The Medicines for All Institute has entered into a partnership with a manufacturer in South Africa to commercialize advances made by the institute to improve...
5 World’s Best Herbal Medicines And Why You Should Try Them
Here are five of the world’s best herbal medicines and the reasons why you should try them. Source link...
STAT Plus: The FDA wants to know how Instagram influencers sway patient views on medicines
In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social media, boosting sales by 21% over just a few months,...
EQRx Launches to Create Innovative Medicines at Dramatically Lower Prices for People, Healthcare Systems and Society
CAMBRIDGE, Mass.–(BUSINESS WIRE)–EQRx announced today that it is launching to create novel, patent-protected medicines at prices that are more affordable for people and sustainable for...
FDA approves Blueprint Medicines’ precision therapy for rare form of gastrointestinal cancer
The agency on Thursday approved Ayvakit (avapritinib) for gastrointestinal stromal tumor, or GIST, that harbors a PDGFRa exon 18 mutation. Still, identifying patients could be...
California May Start Producing Its Own Medicines
Proposal also includes a single market for drug pricing in the state Source link...
California May Start Producing Its Own Medicines
The proposal also includes a single market for drug pricing in the state. Companies would have to bid to sell their medicines at a set...
Opinion: Transforming psychedelics into mainstream medicines
Research on psychedelics, which have been profoundly stigmatized, highly restricted, and tragically undeveloped for more than half a century, is stirring back to life and...
Novel study on molecular interactions could make it easier to develop new medicines
A first-of-its-kind study on molecular interactions by biomedical engineers in the University of Minnesota’s College of Science and Engineering will make it easier and more...
Research shows why people with chronic illnesses turn to the 'black market' for medicines and supplies
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the “black market” for medicines and...
Medical News Today: Do past medicines hold the answer to antibiotic resistance?
As the effectiveness of antibiotics wanes, scientists are looking at medications that preceded them, such as those involving metals and metalloids. Source link...
Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to...
STAT Plus: Pharmalittle: Novartis to pay $9.7 billion for The Medicines Co.; Trump bashes Pelosi drug pricing bill
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, Skype...
The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion
PARSIPPANY, N.J.–(BUSINESS WIRE)—- $MDCO–The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines...
Accelerating Medicines Partnership program for Parkinson’s disease launches new data portal
The Accelerating Medicines Partnership program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy...
The Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing
PHILADELPHIA–(BUSINESS WIRE)—- $MDCO #ASCVD–The Medicines Company (NASDAQ: MDCO) today announced detailed results from ORION-10, the second of three pivotal 18-month low-density lipoprotein cholesterol (LDL-C) lowering...
Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the...
Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports
The only pharmacologic prophylaxis against respiratory syncytial virus (RSV) infection in preterm infants is the humanized monoclonal antibody palivizumab. After the 2014 modification of the...